Why Shares of Illumina Rose 15.3% in January
1 minuto de lectura
What happenedShares of genomics leader Illumina (NASDAQ: ILMN) rose 15.3% in January, according to data provided by S&P Global Market Intelligence. Although the genomics leader didn’t announce any financial updates during the month, it did win a patent lawsuit.Read MoreMarketsMarkets Feed
Descubre más desde Espacioteca
Suscríbete y recibe las últimas entradas en tu correo electrónico.
